Genentech is committed to creating a tomorrow where neurological disorders no longer limit human potential through groundbreaking research, advancing equitable access to care and by closely collaborating with the community.

There are hundreds of neurological disorders that impact nearly 100 million Americans. These disorders can alter the very essence of what makes us human—the way we think, communicate, move and remember.

At Genentech, we are continuing to advance groundbreaking research to discover and develop breakthrough medicines for the most common and rare neurological disorders that have eluded researchers.

As part of this research, we are prioritizing the recruitment of underrepresented communities. We are also deepening engagements with stakeholders across the healthcare system and enhancing support for people from all backgrounds to help ensure more equitable access to care.

We recognize that as populations around the world continue to age, the impact of neurological disorders is expected to increase. This will create new challenges we are prepared to meet by working closer with the community and key partners. This includes contributing to the Institute for Health Metrics and Evaluation (IHME) Brain Health Atlas and raising awareness about why brain health matters.

Through our work, we remain committed to pushing the boundaries of scientific understanding to solve some of the greatest challenges in neuroscience today.